Heroin-induced leukoencephalopathy: Chasing the imaging findings

Area of Science:

• Neurology
• Toxicology
• Radiology

Background:

• Opioid encephalopathies encompass a range of neurological conditions associated with opioid use.
• Heroin inhalational leukoencephalopathy (HLE) is a specific manifestation within this spectrum.
• Distinguishing HLE from other toxic and hypoxic-ischemic encephalopathies is crucial for accurate diagnosis.

Observation:

• A case study of a 29-year-old male presenting with unresponsiveness due to heroin inhalational leukoencephalopathy.
• Detailed neuroimaging and clinical findings specific to HLE.

Findings:

• HLE presents with characteristic patterns of brain involvement, particularly in specific white matter territories.
• Comparison of HLE imaging findings with those of other toxic and hypoxic-ischemic encephalopathies reveals distinct patterns.
• The study aims to clarify the unique radiological signature of HLE.

Implications:

• Enhanced understanding of HLE's distinct neurological and radiological features.
• Improved diagnostic capabilities for differentiating HLE from other cerebral insults.
• Potential for earlier and more accurate diagnosis and management of opioid-induced neurological damage.